Twitter Beğeni Hilesi

With several illustrious guests from Cinci Children’s, The Ohio State University Wexner Medical Center Dr. Benjamin Segal , Nationwide Children's Hospital , OSU Hematology - BMT retreat !

Congrats, Tamra Brooks! 🎈🎉💐 For 27 years (5 w/ the #PIIO) you have been a consummate professional, leader, & all around go-getter‼️We HATE you're leaving, but LOVE 💕 that you will enjoy a well deserved retirement. All the best to you & your family. Love, the Pelotonia Institute for Immuno-Oncology

Happy retirement to the heart and soul of Pelotonia Institute for Immuno-Oncology - Ms. Tamra Brooks, my amazing EA who was involved in getting me here from day one and has helped us to make what #PIIO is today! We will miss you so dearly Tam!!

Join us Aug 20 at NOON for the #Immunology, #Infection, & #ImmunoOncology (i3) Seminar Series, where Dr. Wan-Lin Lo will discuss "T-Be-Developed: Diverse Signals, Diverse Fates" in 170 DHLRI (with viewing at EAIC130). #MIIProud, Ohio State Rheumatology Pelotonia Institute for Immuno-Oncology

🚨 Exciting news‼️ The James, #PIIO researcher Dr. Zihai Li, MD, PhD & Team rec'd a National Cancer Institute R01 for their groundbreaking work on "Targeting GARP-TGFβ for #Immunotherapy of #NSCLC." This project aims to restore #Tcell activity against #lungcancer & move their #MonoclonalAb PIIO-1 closer

🎉 Congratulations to Drs. Dongjun Chung & Qin Ma BMBL on their new MPI NIGMS grant titled "Statistical Power Analysis Framework for Multi-Sample and Cross-Platform Spatial Omics Experiments"! This project aims to enhance #SpatialOmics study design, which is crucial for

Honored by Carl June guiding our cell therapy program within Pelotonia Institute for Immuno-Oncology and Zihai Li, MD, PhD with Dr. Ashley Krull, Ph.D. and Dr Lynn O'Donnell

Many thanks to everyone who led & participated in the Pelotonia Institute for Immuno-Oncology ESAB & Strategic Planning Summit. PIIO 2.0 will be phenomenal because of your tireless efforts to position the #PIIO as a Leader in Driving #ImmunoOncology Breakthroughs. Special thanks to ESAB Members Drs.

The Pelotonia Institute for Immuno-Oncology Annual Report highlights new recruits, scientific accomplishments, education updates & more! Many thanks to our #PIIOcommunity for supporting our ambition of being a leader in driving #ImmunoOncology breakthroughs. go.osu.edu/piioannualrepo…

Join us Today Aug 27 at NOON for the #Immunology, #Infection, & #ImmunoOncology (i3) Seminar Series, where Dr. Marco Colonna will discuss "Exploring the Diversity of RORyt Cells in the Intestinal Mucosa" in 170 DHLRI (with viewing at EAIC130). The i3 seminar series is a new

Learn how Ohio State experts are reducing some side effects of #immunotherapy, a revolutionary class of cancer treatments. health.osu.edu/health/cancer/…

An incredible turnout for our i3 seminar featuring Marco Colonna The Colonna Lab. An engaging and insightful session with the OSU i3 community. #sciencerocks Pelotonia Institute for Immuno-Oncology The Ohio State University Wexner Medical Center The Ohio State University College of Medicine

📢 Join us for our #PIIO Research in Progress seminar on "Targeting the Tumor Microenvironment of #PancreasCancer: The Roles of CXCR4 and Focal Adhesion Kinase," presented by Dr. Alex Blair, incoming Assistant Professor, Ohio State Wexner Medical Center Surgery Dept.. The Ohio State University Wexner Medical Center, The James. Don't miss

Dr. Jacob Kaufman Explains Tissue vs. Liquid Biopsies in Lung Cancer Diagnosis. Discover more in the link. #LiquidBiopsy #TissueBiopsy #LungCancerResearch bit.ly/4g00sJG

Congratulations to Dr. Haitao Wen & team on their new research published in eLife - the journal that reveals that O-GlcNAc transferase (OGT) promotes #tumor growth by repressing the cGAS-STING pathway, impacting #antitumor #immunity. Targeting OGT could enhance immune response in

Join us Today SEPT 3 at NOON for the #Immunology, #Infection, & #ImmunoOncology (i3) Seminar Series, where Dr. Yuxuan Miao will discuss "Decoding the Dialogue between Epithelial Stem Cells and the Immune System" in EAIC 130 (with viewing at DHLRI 170). The i3 seminar series is a

#Immunotherapy innovation is underway Pelotonia Institute for Immuno-Oncology, where experts are working everyday to harness the body's own defenses to treat #cancer. Learn the latest on our Cancer-Free World Podcast. soundcloud.com/thejamescancer…

Kudos to this year's recipients of the @ohiostatemed Research Innovation Career Development Award! This funding provides support for promising early career clinician scientists to maintain momentum of their investigations. Looking forward to seeing what these innovators discover!

Many thanks to #MIIProud, #PIIO researcher Dr. Hazem Ghoneim for his enlightening research-in-progress seminar, "Modeling #Epigenetic Programming of #TCellExhaustion Reveals the Microenvironment Role in #TCell Fate." Dr. Ghoneim's research focuses on identifying novel

🎉 Congratulations to Dr. Steve Oghumu on receiving an NIH grant for his research on "The oral #glucocorticoid system in #oral_carcinogenesis and its modulation for improved treatment outcomes"! 🥳 His work explores #genetic and #immunological factors in disease, focusing on